Scientists May Have Found How Aggressive Prostate Cancer Resists Treatment
Summary
Scientists at Fred Hutch Cancer Center discovered that a molecule called transfer RNA (tRNA) can influence how aggressive prostate cancer cells respond to treatment. Their research suggests that adjusting tRNA levels may help make drug-resistant prostate cancer more sensitive to therapy.Key Facts
- Prostate cancer is the second-leading cause of cancer death in American men.
- tRNA is a molecule that helps produce proteins by bringing building blocks called amino acids to cells.
- The study found that tRNA can reduce proteins that prostate cancer drugs target, affecting treatment success.
- Increasing tRNA might help prevent prostate cancer from becoming resistant to drugs.
- The research was published in the journal Nature on October 7, 2026.
- Some companies are already developing treatments based on tRNA.
- Advanced prostate cancer often becomes resistant to hormone therapy, chemotherapy, and other treatments.
- This discovery could lead to new ways to treat aggressive and drug-resistant prostate cancer.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
